Maryam Farmani
Islamic Azad University
16 Papers
28 Citations
Maryam Farmani is an academic researcher from Islamic Azad University. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Blue luminescent graphene quantum dot conjugated cysteamine functionalized-gold nanoparticles (GQD-AuNPs) for sensing hazardous dye Erythrosine B.
TL;DR: Results demonstrate that ErB can quench fluorescence of GQD-AuNPs conjugates, considerably, and use of this good interaction for construction sensor for detection of ErB.
32
Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
Seyed Mobin Khoramjoo,Nesa Kazemifard,Shaghayegh Baradaran Ghavami,Maryam Farmani,Shabnam Shahrokh,Hamid Asadzadeh Aghdaei,Ghazal Sherkat,Mohammad Reza Zali +7 more
TL;DR: The components and signaling of Wnt, Notch, and Hippo pathways and their role in the intestine and immune system are summarized and latest scientific literature on the crosstalk among these three signaling pathways in IBD is reviewed.
Identifying and Evaluating Risks of Construction Projects in Fuzzy Environment: A Case Study in Iranian Construction Industry
TL;DR: A quantitative method based on the fuzzy analytic hierarchy process (AHP) approach to manage the risk of construction projects in the uncertain environment is presented and it covers uncertainty present in the experts' opinions.
The critical role of gut-brain axis microbiome in mental disorders.
Shaghayegh Baradaran Ghavami,Maryam Farmani,Nesa Kazemifard,Amin Sadeghi,Ensieh Lotfali,Hamid Asadzadeh Aghdaei +5 more
TL;DR: The role of the largest and most repetitive bacterial community and their relevance with some diseases that they have mentioned previously are reviewed and focused on.
17
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Mohammad Reza Hatamnejad,Shaghayegh Baradaran Ghavami,M Ahmad Shirvani,Mona Asghari Ahmadabad,Shabnam Shahrokh,Maryam Farmani,Ghazal Sherkat,Hamid Asadzadeh Aghdaei,Mohammad Reza Zali +8 more
TL;DR: The molecular mechanisms and clinical evidence are scrutinized and integrated to clarify the interfering molecular mechanism justifying both supporting and disproving clinical evidence.